吸食重大麻与酒精使用者肝病风险降低相关联,但专家警告不要将大麻用于保护。 Heavy cannabis use linked to lower liver disease risk in alcohol users, but experts warn against using it for protection.

对有酗酒障碍的66 000多名美国成人进行的一项研究发现,吸食大麻的重饮者与酒精有关的肝病发病率较低,而那些吸食大麻的狂食者的风险较低40%,同时严重肝病并发症和死亡风险也较低。 A study of over 66,000 U.S. adults with alcohol use disorder found that heavy drinkers who used cannabis had lower rates of alcohol-associated liver disease, with those having cannabis use disorder showing 40% lower risk, along with reduced risks of severe liver complications and death. 研究人员认为,Cannabidiol(CBD)可以减少肝炎,改善脂肪新陈代谢,但强调调查结果显示,由于自身健康风险,使用大麻来保护肝脏是有关联的,而不是因果关系,并告诫不要使用大麻来保护肝脏。 Researchers suggest cannabidiol (CBD) may reduce liver inflammation and improve fat metabolism, but stress the findings show association, not causation, and caution against using cannabis for liver protection due to its own health risks. 需要进一步的临床试验来确定安全的CBD剂量,因为FDA仅批准CBD用于特定的发作. Further clinical trials are needed to determine safe CBD doses, as the FDA has only approved CBD for specific seizure disorders.